Effect of Evolocumab on Vascular Function

Summary

Effect of Evolocumab on Vascular Function is a clinical trial^[1].

Key Facts

• Effect of Evolocumab on Vascular Function is in the country of Germany^[2].
• Effect of Evolocumab on Vascular Function's instance of is recorded as clinical trial^[3].
• Effect of Evolocumab on Vascular Function's start time is recorded as +2018-11-01T00:00:00Z^[4].
• Effect of Evolocumab on Vascular Function's end time is recorded as +2019-12-31T00:00:00Z^[5].
• Effect of Evolocumab on Vascular Function's main subject is recorded as atherosclerosis^[6].
• Effect of Evolocumab on Vascular Function's number of participants is recorded as {'unit': '1', 'amount': '+65'}^[7].
• Effect of Evolocumab on Vascular Function's title is recorded as Randomized, Double-blind, Placebo Controlled, Parallel-group, Prospective Clinical Study to Analyse the Effect of Evolocumab on Vascular Function^[8].
• Effect of Evolocumab on Vascular Function's short name is recorded as EVO^[9].
• Effect of Evolocumab on Vascular Function's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+40'}^[10].
• Effect of Evolocumab on Vascular Function's ClinicalTrials.gov ID is recorded as NCT03626831^[11].
• Effect of Evolocumab on Vascular Function's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}^[12].
• Effect of Evolocumab on Vascular Function's research intervention is recorded as evolocumab^[13].
• Effect of Evolocumab on Vascular Function's clinical trial phase is recorded as phase IV clinical trial^[14].
• Effect of Evolocumab on Vascular Function's research site is recorded as Friedrich-Alexander-Universität Erlangen-Nürnberg^[15].
• Effect of Evolocumab on Vascular Function's study type is recorded as interventional study^[16].